Introduction
The HIV program in India has evolved dramatically over the last decade. Preventive and behavior change strategies, along with a scaled-up program for coverage of antiretroviral therapy (ART), have led to a nearly 50% decrease in the estimated number of new HIV infections in India-from 250,000 in 2001 to 120,000 in 2012 [1] .
The HIV epidemic in India is concentrated in nature and heterogeneous in distribution [2] . Heterosexual transmission remains the most important driver for HIV transmission among the general population whereas intravenous drug use, men having sex with men, and migrant population are a high risk population [2] . The prevalence of HIV among antenatal clinic attendees had shown a declining trend. Adult HIV prevalence in India had declined to an estimated 0.31% (0.25% -0.39%) in 2009 against 0.36% (0.29% -0.45%) in 2006. Penetration of the epidemic in the general population has resulted in an increased burden of HIV among children in recent years [3] . Seven percent of the total HIV cases were among children aged less than 14 years [1] . Estimates suggest 14,500 incident HIV infections annually among children, assuming a vertical transmission rate of 30% [1] . UNAIDS has reported an increase in the number of children living with HIV (CLHIV) between 2001 and 2011 [4] . Evidence suggests an overall risk of parent to child transmission through breast feeding up to 18 -24 month of age, in the absence of any intervention, to be 30% -45% [5] . However, interventions for prevention of parent to child transmission have been significantly scaled up in the country, which has led to a lower parent to child HIV transmission rate.
Since 2012, the policy of single dose nevirapine prophylaxis has changed to a more effective multi-drug regimen [3] . The current strategy is to provide life-long ART to pregnant women (Option B plus) [5] . Identification of HIV exposed fetuses during the antenatal period is the cornerstone to enhancing the subsequent survival of HIV infected children. Apart from antenatal prophylaxis, a number of other factors, such as feeding practices and type of delivery, also play a role in transmission of HIV infection to the child. Survival of HIV infected children depends on various factors like early infant diagnosis, early entry into care, access to care, and socio-demographic characteristics. Enhancement of care, support and treatment in the form of provision and universal roll-out of anti-retroviral therapy (ART) have also improved the survival of CLHIV [5] . Higher access to ART services has decreased the mortality rate in CLHIV. The estimated 260,000 children who died from AIDS-related illnesses in 2009 were 19% fewer than the estimated 320,000 who died in 2004 [4] . However, adherence to treatment is an important challenge in prolonging the survival of CLHIV. Thus, there are a multitude of factors that impact the transmission of HIV from parent to child, and the subsequent survival of infected children. Most of the literature published from India has an inadequate sample size and have not been conducted in a sufficiently robust manner. Many studies have relied on programmatic data, whose quality is uncertain. Thus, it is necessary to conduct a systematic review to synthesize the existing literature on parent to child HIV transmission, survival and treatment of CLHIV. The only available systematic review published from India has not focused on these aspects, but has mainly presented findings on utilization and access to prevention of parent to child transmission (PPTCT) services [6] .
In this paper we present findings from a systematic review of the literature published from India regarding parent to child transmission of HIV and treatment and survival of CLHIV.
Methods

Literature Search Strategy
We conducted a comprehensive search to identify all relevant studies related to parent to child transmission of HIV, treatment and survival of CLHIV (Box 1). We searched the following databases: Medline, Pubmed, IndMED, and used search engines like Web of Science and Google Scholar. To locate additional studies and reports, we screened the table of contents of journals that publish studies related to HIV/AIDS and scanned the websites of national and international organizations like National AIDS Control Organization (NACO), World Health Organization (WHO), United States Agency for International Development (USAID), and United Nations Program on HIV/AIDS(UNAIDS). We also searched the reference lists of articles included in the systematic review.
Study Selection
We conducted the search using three sets of key words. 1) Prevention of Parent to Child Transmission OR PPTCT, Parent to Child Transmission OR MTCT, Antenatal prophylaxis, Nevirapine prophylaxis, Option B regimen, Type of delivery, Delivery, Caesarean, Infant feeding, Mixed Feeding, Replacement feeding, Sero-discordance, AND India; 2) Survival, Early Infant Diagnosis, Access to care, CD 4 count, Adherence, AND India AND HIV and Children OR Pediatric; 3) Anti-retro Viral Therapy OR ART, Adherence, Effectiveness, Efficacy, Survival, AND India AND Children OR Pediatric. The search was restricted to studies published between 1992 and 2015. All studies published in English or with a detailed summary in English were included in the review. The search was conducted in January 2015.
Data Extraction
We screened the titles of all the search outputs, and excluded studies that were not found to be relevant. Abstracts of all the titles found to be relevant to the present review were screened, and those that met in the inclusion criteria, as given in Box 1, were included. We exported the search results to EndNote reference manager software. A structured data extraction sheet was used, based on the Cochrane data extraction sheet and the New Castle Ottawa scale. Quality assessment for randomized control trials was done using a five-point scale, namely the process of randomization, treatment allocation, baseline comparability, blinding and drop-out rate. However, we did not screen or exclude studies based on methodological quality as the purview of this review was exploration rather than estimation. Data extraction was done under the following heads: domain and sub-domain of the study, study identifier i.e. last name of author, year of study and publication, PubMed ID, study characteristics (study design, study setting, objective, sample size, and inclusion and exclusion criteria), participant characteristics for studies related to survival and treatment (sex wise, mean age, and age group), objective, exposure, outcome and important findings, drop-out rate and adjustment for confounders.
Results
Search Results and Thematic Categorization
We retrieved a total of 842 titles from the search term alone or in various combinations. Of these, 686 were not found to be relevant to the present review or were duplicate searches-i.e. the same title retrieved from different Box 1. Study selection criteria.
A) Inclusion criteria 1
Studies in English or those with a detailed summary in English.
2
Studies published between January 1992 and January 2015.
3
Primary research conducted in India; either community or facility based.
4
Study population: HIV-infected pregnant women, HIV-exposed or HIV-infected children (≤14 years). 
Salient Characteristics of the Selected Studies
All the studies included in the review were conducted after 2000, and were health facility-based studies. Most (88%) were conducted in urban public health facilities. While around half were conducted in the high HIV prevalence states of Andhra Pradesh, Tamil Nadu and Maharashtra, 20% were conducted in West Bengal and 10% in Gujarat. Only three studies were conducted in the states of north India. In all, 28 studies were interventional or observational follow-up studies, 2 were cross-sectional studies and 3 were retrospective cohort studies ( Table 1 ).
Parent to Child Transmission of HIV
Most studies explored the effectiveness of single dose nevirapine prophylaxis, and were conducted in a public health facility in southern India. All except two studies had a sample size of between 30 and 1890 HIV infected pregnant women.
The HIV sero-positivity rate among antenatal women ranged from 0.17% to 0.56% [13] [15] [22] . HIV transmission from HIV-infected parent to child who received nevirapine prophylaxis ranged from 2.1% to [7] Andhra Pradesh (Rural) 523
The overall HIV transmission rate from parent to child was 3.7%. The cumulative 12-month mortality was 9.6% for formula-fed infants versus 0.68% for breastfed infants. Of the 41 infants who received nevirapine prophylaxis, the overall transmission rate up to the age of one year was 8%. The transmission rate in exclusively formula fed infants was 3.1% (1/31) vs 30% (3/10) in the mixed feeding group. 
The HIV transmission rate among infants delivered through cesarean section was 2.9% (1/35) and 4.1% (2/49) for vaginal delivery at 18 months of age. With respect to feeding practice the transmission rate was 25% for those in the mixed feeding group, 2.4% for those exclusively breast fed and 0% for those exclusively formula fed.
Among infants who received single dose nevirapine prophylaxis and tested for HIV at age one year, the transmission rate was 3.1%. 1/32). The HIV transmission rate for infants delivered through cesarean section was 1.1% (2/174). And for vaginal delivery it was 2.1% (1/48). Thus, elective cesarean section was not statistically better as compared to vaginal delivery (p = 0.8696) in presence of ART during pregnancy and absolute formula feeding during first six months.
15
SWEN study team (2008) [21] Maharashtra (Urban) 770
The HIV transmission rate at 6 months of age among HIV exposed infant who received single dose nevirapine prophylaxis was 9.6 % (87/901) whereas it was 6.3% (62/986) among those who received extended dose regimen. relative risk of acquiring HIV in infants was 0.80 (RR = 0.80, 95% C.I. 0.58 -1.10) when given extended dose regimen as compared to a single dose regimen The outcome of ART in terms of survival was not affected by the orphan status. Improvement in nutritional parameters and CD4 count was comparable in both the groups. Following ART, a reduction in wasting was noted in 75.0% of children ≤5 years of age, whereas only 44.4 % of underweight children >5 years of age showed an improvement after therapy. Tamil Nadu (NM) 288
The median percentage of CD4+ T cells was 15%. The percentage of children who reached the primary end point was significantly higher in the nevirapine group than in the ritonavir-boosted lopinavir group (40.8% vs. 19.3%; p < 0.001). The time to a protocol-defined toxicity end point was shorter in the nevirapine group (p = 0.04), as was the time to death (p = 0.06).
10
De et al. (2012) [33]
West Bengal (Urban) 94 Fifty-six percent of respondent parents and 65.8% of respondent children showed good adherence to ART.
11
Rajashekharan et al. (2009) [34]
Tamil Nadu (Urban) NA
The cumulative survival probability at 6, 12, 18, 24 and 30 months was 93%, 90%, 89.7%, 89.7% and 89.7%, respectively. Of the children who died, about 50% died within the first month. Nearly 6% of the children had adherence less than 95%. The children who had a baseline CD4 % less than or equal to 14% had significantly (p < 0.05) higher mortality as compared to children who had 20% or more.
Survival of children living with HIV 1
Alvarez Uria G. et al. (2013) [36] Andhra Pradesh (Rural) 523
Predictors for delayed entry into care and survival were; diagnosed after knowing that parent is HIV positive, age less than 18 month, alive parent, female sex, diagnosed at earlier calendar years, distance at ART center >90 minutes . [20] . In a study conducted in a secondary care setting, the parent to child transmission rate was 5.2% among 154 parent-baby pairs who were fully compliant with the then existing protocol of nevirapine prohylaxis, as compared to 17.5% among non-compliant pairs [10] . In a study conducted in 33 PPTCT centers in 18 districts of Gujarat, infants who received ART for prevention were at lower risk of HIV infection than those who did not (5.2% vs 41.1%, p value < 0.0001) [12] . A study in West Bengal comparing the efficacy of a single dose versus an extended dose regimen found that the HIV transmission rate in the former group was 8.9% as compared to 10.4% in the latter group [17] . However, the difference was not statistically significant. Cumulative mortality in the extended dose regimen group was also significantly less (risk ratio = 0.53, 95% CI 0.32, 0.85) than in the single dose regimen group [17] . In a study in Maharashtra, the relative risk of acquiring HIV in infants was 0.80 (RR = 0.80, 95% C.I. 0.58 -1.10) when given extended dose regimen as compared to a single dose regimen [21] . Few studies compared the HIV transmission rate with respect to feeding patterns. A study in Maharashtra showed that infants who were exclusively formula fed had a lower transmission rate than the overall transmission rate (3.1% vs 8.0%) [11] . Similar results were seen in studies in Gujarat where the transmission rate was 6.2% in the replacement feeding group as compared to 25.5% in the breast-feeding or mixed feeding group [12] . A study in West Bengal compared the efficacy of both perinatal nevirapine prophylaxis and feeding patterns in a single arm, and found that whereas the HIV transmission rate without any of these interventions was 57.2%, it reduced to 15% in the presence of intervention with nevirapine prophylaxis and total formula feeding [15] . However, contrary results were obtained in a study in Tamil Nadu, where the HIV transmission rate among breast-fed infants was zero percent, compared to 6.5% for the entire cohort [18] .
Most of the studies which compared the HIV transmission rate with respect to type of delivery showed that cesarean section was better than vaginal delivery in preventing HIV transmission. In a cohort study in Gujarat, the transmission rate in the vaginal delivery group was 4.1% as compared to 2.9% among mothers who underwent cesarean section [23] . However, one study in Maharashtra showed that cesarean section delivery was not better than vaginal delivery in reducing the HIV transmission rate [20] .
The presence of concomitant chronic conditions was also found have an effect on transmission of HIV. The parent to child transmission rate among pregnant women co-infected with HIV-TB was 30%, which was significantly more than the transmission rate of 12% in the absence of tuberculosis (p value = 0.02) [24] .
Treatment of Children Living with HIV
Of the 11 studies covering treatment of CLHIV, four explored levels of ART adherence, and factors associated with non-adherence to treatment; 2 examined the magnitude of loss to follow up among children on ART care, and 3 explored the effectiveness of different highly active anti-retroviral therapy (HAART) regimens in the treatment of HIV-infected children.
The attrition rate for ART among children (14 years or less) living with HIV on ART was 12.6% and 15.6% in two studies conducted in Andhra Pradesh [25] [26] . Children from the lower socio-economic group, orphans, males and younger children (aged less than two years) had a higher likelihood of attrition and thus subsequent mortality than others. Children with lower annual risk of AIDS were more likely to be lost to follow up but had less chance of mortality than others. Improvement in nutritional status was noted in terms of reduction in wasting, increase in body weight z score, and improvement in hemoglobin after the initiation of HAART [28] [29] [35] ; Children showing an improvement in these parameters had a lower risk of subsequent mortality than others.
Appropriate adherence to ART (more than 95% of doses) varied from 65.8% to 95.5% across studies [28] [32] [34] . In a study conducted in a pediatric center for excellence for HIV care, which assessed adherence to treatment using the pill count and three-day recall period methods, appropriate adherence was more than 95%. Reasons for non-adherence cited by caregivers were multiple caregivers, work constraints of the caregiver, and death or illness in the family [28] . However, a study in an ART center in Delhi reported low adherence (less than 95% of doses) in 34.4% of the children who had initiated ART. Factors associated with low adherence were low educational status of the caregiver, late initiation of ART after diagnosis, orphan status and female sex [28] . Thus, there was a considerable difference in the adherence rate in the two types of settings. One study in Tamil Nadu showed that mortality and drug resistance among children 2 -36 months of age were higher in a nevirapine alone regimen as compared to a protease inhibitor boosted lopinavir regimen [33] .
Survival of Children Living with HIV
Of the three studies that assessed the survival pattern of CLHIV, one study each reported time to infant diagnosis, time of entry into care and CD 4 count at the time of diagnosis as factors related to survival. CD 4 count at the time of diagnosis was an important predictor of progression of HIV [37] . Children with a baseline CD 4 count of less than or equal to 14% had significantly higher mortality as compared to children with a CD 4 count of more than 20% [38] . Delayed age at diagnosis had an adverse impact on the overall long-term outcome of the disease and subsequent mortality. Attrition of children diagnosed with HIV before being initiated on treatment was an important factor in the progression of the disease and subsequent mortality [36] .
In a cohort study in South India, 13% of the children were lost to follow up in the one year after diagnosis. Most of the children who were not eligible for treatment during the first year were lost to follow up [37] . Children who had a delayed entry into care after ART eligibility were those diagnosed after their parent's HIV diagnosis, less than 18 months of age, female, orphan, and living more than 90 minutes from the nearest HIV center [38] .
Discussion
We found that the majority of research in India has focused on the effectiveness of interventions related to nevirapine prophylaxis. However, the Government of India has decided to roll-out and scale-up the Option B plus regimen, a conclusively effective regimen [39] . However, there is a scarcity of literature related to the effectiveness of life-long ART for pregnant women in India. Our review reveals that most studies are from high HIV prevalence states of India and conducted in urban areas. Operation research covering wider geographical areas is needed since HIV among children is no longer restricted to high prevalence states [40] .
The provision of exclusive formula feeding during the first six months of life is beneficial in reducing parent to child transmission of HIV. However, due to the socio-economic context in the Indian setting, consensus has been built to continue with exclusive breast-feeding during the first six months of life [41] .
Most of the studies that explored issues around the treatment of CLHIV explored ART adherence and loss to follow up, and only a few studied the effectiveness of HAART. After initiating a child on ART, frequent monitoring is critical for assessing well-being as well as side effects and adherence. Monitoring should also focus on the general growth, development, immunization status as well as nutritional status. Visits should also be used as an opportunity to educate and counsel parents and care-givers on adverse drug reactions, opportunistic infections and adherence. Local evidence and operational challenges in this regard are lacking and call for adequately sampled prospective cohort studies.
Increase in accessibility to HIV treatment for the pediatric population has led to an increase in long-term survival [4] . In the present review, studies have focused mainly on outcome measures with the determinant being CD 4 count. These studies are conspicuous by being few in number and concentrated in few southern states. Factors such as access to care, socio-economic context, and tracking of children as parent-child pairs should be new areas of research, which could suggest measures to increase the survival of CLHIV and start on ART. There is a need to conduct long-term follow-up studies to explore the association between patterns and ART access in Indian settings.
Assessments are needed of the knowledge gap among the cadre of health care workers in light of new HIV treatment guidelines, implementation challenges and training needs. Evidence is also needed to improve prevention and treatment of malnutrition among HIV-exposed and HIV-infected children. Presently there is little information available on the effectiveness of nutritional interventions among HIV-infected children.
Disclosing the diagnosis of HIV to an HIV-infected child is an emotionally charged issue for parents and health care providers. The present status of research on HIV among children in India is completely missing in this regard. There have been many studies on disclosure related to patients with cancer, and lessons may be drawn for HIV [42] .
Conclusion
Most of the studies included in this systematic review have been small unplanned studies, conducted as a part of routine health care delivery related to HIV. Shift in policy to provide option B regimen is yielding better results. Various factors identified as the determinants of transmission of HIV from parent to child need to be targeted. If the age at diagnosis could be reduced further, it would increase the survival of children living with HIV. The program needs to increase access to the health care facilities to improve adherence rate and reduce attrition.
Recommendation
Universalization and increased uptake of the newer and more effective Option B plus regimen is recommended.
There is need to conduct operational research to document the effectiveness of life-long ART in pregnant women in preventing parent to child transmission of HIV in the Indian setting. Tracking of children exposed with HIV should be done as parent-child pairs, with strict follow-up. A more robust follow-up strategy should be implemented under the program. There is a need to target various modifiable programmatic factors associated with poor treatment adherence, including type of treatment setting and late initiation of ART after diagnosis. There is a need to conduct more scientifically robust studies to facilitate programmatic recommendations.
